FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022843485> ?p ?o ?g. }

• W2022843485 endingPage "512" @default.
• W2022843485 startingPage "503" @default.
• W2022843485 abstract "To develop a rational immunotherapy against tumor metastasis by combining a Toll-like-receptor 2 (TLR2)-neutralizing antibody with a TLR9 agonist CpG ODN, and then investigate the mechanism of action for this combinational regimen.After mouse melanoma B16-F10 cell inoculation, female C57BL/6 mice were treated with either CpG ODN (0.5 mg/kg) or the anti-TLR2 antibody (200 μg/kg), or with a combination of the two agents. Pulmonary metastases were evaluated by counting metastatic nodes on the lung surface using anatomical microscopy. Flow cytometry was used to evaluate the cytotoxicity of the immune cells in tumor-draining lymph nodes, the cell population in the spleen, and the infiltration of immune cells within the lungs. Cytokine and enzyme expression in the lung tissue was evaluated using ELISA or immunostaining.Anti-metastatic effects were detected in mice treated with either CpG ODN or the anti-TLR2 antibody alone. However, treatment with CpG ODN plus the anti-TLR2 antibody synergistically suppressed the metastasis as compared with treatment with either single agent. The combinational treatment resulted in enhanced infiltration of natural killer cells and cytotoxic T cells, reduced recruitment of type 2 macrophages and Tregs, and decreased expression of immunosuppressive factors including TGF-β1, cyclooxygenase-2 and indoleamine 2,3-dioxygenase, thus stimulated tumor cytotoxicity and suppressed metastasis. The anti-metastatic effect of the combinational regimen was further confirmed in spontaneous metastatic mouse model of Lewis lung carcinoma.Our studies suggest that combining a TLR9 agonist with an anti-TLR2 antibody, which eliminates immunosuppressive factors from the tumor environment, is critical for an effective anti-metastatic immunotherapy." @default.
• W2022843485 created "2016-06-24" @default.
• W2022843485 creator A5008464561 @default.
• W2022843485 creator A5016853386 @default.
• W2022843485 creator A5042414626 @default.
• W2022843485 creator A5048297033 @default.
• W2022843485 creator A5091003916 @default.
• W2022843485 date "2012-03-19" @default.
• W2022843485 modified "2023-10-07" @default.
• W2022843485 title "Simultaneous TLR2 inhibition and TLR9 activation synergistically suppress tumor metastasis in mice" @default.
• W2022843485 cites W1678648653 @default.
• W2022843485 cites W1896668130 @default.
• W2022843485 cites W1965917728 @default.
• W2022843485 cites W1967060514 @default.
• W2022843485 cites W1976707323 @default.
• W2022843485 cites W1980219117 @default.
• W2022843485 cites W1985652465 @default.
• W2022843485 cites W1988246030 @default.
• W2022843485 cites W1989748451 @default.
• W2022843485 cites W1992271872 @default.
• W2022843485 cites W2000734931 @default.
• W2022843485 cites W2011753823 @default.
• W2022843485 cites W2020509129 @default.
• W2022843485 cites W2021627528 @default.
• W2022843485 cites W2046527429 @default.
• W2022843485 cites W2050841284 @default.
• W2022843485 cites W2071130348 @default.
• W2022843485 cites W2092909221 @default.
• W2022843485 cites W2095949127 @default.
• W2022843485 cites W2097062765 @default.
• W2022843485 cites W2104263144 @default.
• W2022843485 cites W2109491705 @default.
• W2022843485 cites W2112078889 @default.
• W2022843485 cites W2117684163 @default.
• W2022843485 cites W2122541507 @default.
• W2022843485 cites W2124310819 @default.
• W2022843485 cites W2131778873 @default.
• W2022843485 cites W2134538505 @default.
• W2022843485 cites W2161091841 @default.
• W2022843485 cites W2783142245 @default.
• W2022843485 doi "https://doi.org/10.1038/aps.2011.193" @default.
• W2022843485 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4003363" @default.
• W2022843485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22426694" @default.
• W2022843485 hasPublicationYear "2012" @default.
• W2022843485 type Work @default.
• W2022843485 sameAs 2022843485 @default.
• W2022843485 citedByCount "14" @default.
• W2022843485 countsByYear W20228434852013 @default.
• W2022843485 countsByYear W20228434852014 @default.
• W2022843485 countsByYear W20228434852016 @default.
• W2022843485 countsByYear W20228434852017 @default.
• W2022843485 countsByYear W20228434852018 @default.
• W2022843485 countsByYear W20228434852019 @default.
• W2022843485 countsByYear W20228434852020 @default.
• W2022843485 countsByYear W20228434852021 @default.
• W2022843485 crossrefType "journal-article" @default.
• W2022843485 hasAuthorship W2022843485A5008464561 @default.
• W2022843485 hasAuthorship W2022843485A5016853386 @default.
• W2022843485 hasAuthorship W2022843485A5042414626 @default.
• W2022843485 hasAuthorship W2022843485A5048297033 @default.
• W2022843485 hasAuthorship W2022843485A5091003916 @default.
• W2022843485 hasBestOaLocation W20228434851 @default.
• W2022843485 hasConcept C104317684 @default.
• W2022843485 hasConcept C136449434 @default.
• W2022843485 hasConcept C150194340 @default.
• W2022843485 hasConcept C154317977 @default.
• W2022843485 hasConcept C159654299 @default.
• W2022843485 hasConcept C190727270 @default.
• W2022843485 hasConcept C202751555 @default.
• W2022843485 hasConcept C203014093 @default.
• W2022843485 hasConcept C22801619 @default.
• W2022843485 hasConcept C2777701055 @default.
• W2022843485 hasConcept C2779138994 @default.
• W2022843485 hasConcept C2781236682 @default.
• W2022843485 hasConcept C40677261 @default.
• W2022843485 hasConcept C502942594 @default.
• W2022843485 hasConcept C542903549 @default.
• W2022843485 hasConcept C55493867 @default.
• W2022843485 hasConcept C71924100 @default.
• W2022843485 hasConcept C86803240 @default.
• W2022843485 hasConcept C8891405 @default.
• W2022843485 hasConceptScore W2022843485C104317684 @default.
• W2022843485 hasConceptScore W2022843485C136449434 @default.
• W2022843485 hasConceptScore W2022843485C150194340 @default.
• W2022843485 hasConceptScore W2022843485C154317977 @default.
• W2022843485 hasConceptScore W2022843485C159654299 @default.
• W2022843485 hasConceptScore W2022843485C190727270 @default.
• W2022843485 hasConceptScore W2022843485C202751555 @default.
• W2022843485 hasConceptScore W2022843485C203014093 @default.
• W2022843485 hasConceptScore W2022843485C22801619 @default.
• W2022843485 hasConceptScore W2022843485C2777701055 @default.
• W2022843485 hasConceptScore W2022843485C2779138994 @default.
• W2022843485 hasConceptScore W2022843485C2781236682 @default.
• W2022843485 hasConceptScore W2022843485C40677261 @default.
• W2022843485 hasConceptScore W2022843485C502942594 @default.
• W2022843485 hasConceptScore W2022843485C542903549 @default.
• W2022843485 hasConceptScore W2022843485C55493867 @default.
• W2022843485 hasConceptScore W2022843485C71924100 @default.

• next